Vidyya Medical News Service
Volume 5 Issue 283 Published - 14:00 UTC 08:00 EST 10-Oct-2003 Next Update - 14:00 UTC 08:00 EST 11-Oct-2003
little clear gif used for spacer

Decreased recurrence: International trial concludes women should take letrozole after five years of tamoxifen treatment
A Canadian-led international clinical trial has found that post-menopausal survivors of early stage breast cancer who took the drug letrozole after completing an initial five years of tamoxifen therapy had a significantly reduced risk of cancer recurrence compared to women taking a placebo. The results of the study appear in an advance on-line edition of the New England Journal of Medicine.  more

Information for patients: Questions and answers about Letrozole and breast cancer
Letrozole is a drug that has recently been shown to provide additional protection for women at risk of recurrent breast cancer. A woman who has had breast cancer surgery and received tamoxifen for five years may further reduce her risk by almost 50 percent by taking letrozole.  more


Rejection hurts
Two key areas of the brain appear to respond to the pain of rejection in the same way as physical pain, a UCLA-led team of psychologists reports in the Oct. 10 issue of Science.  more

Antibiotic therapy for Alzheimer's?
The Alzheimer's Association expressed caution about new research on two antibiotics as possible treatments for Alzheimer's disease based on a study presented today at the Annual Meeting of the Infectious Diseases Society of America (IDSA).  more

It isn't what you say, it's how you say it: Doctor's communication style sways patient participation in clinical trials
New evidence gathered in a study funded by the National Institute of Environmental Health Sciences suggests that asthmatic children who use maintenance medication are particularly vulnerable to the effects of ground-level ozone, even at levels well below the federal standard set by the Environmental Protection Agency.  more

little clear gif used for a space